Reporter March 2 2018
Mar. 1, 2018—A Vanderbilt University Medical Center telemedicine initiative seeks to broaden access to advancements in stroke care for residents of rural counties in Tennessee.
Mar. 1, 2018—The Nashville Collaborative, a partnership between Monroe Carell Jr. Children’s Hospital at Vanderbilt and the Nashville Metropolitan Board of Parks and Recreation, is launching a new program called Teaching Kitchen Outreach.
Mar. 1, 2018—Infants who have higher amounts of the bacterium Lactobacillus present in their nose or upper part of the throat during an acute respiratory syncytial virus (RSV) infection are less likely to develop childhood wheezing later in life, a new Vanderbilt-led Center for Asthma Research study found.
Mar. 1, 2018—Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.
Mar. 1, 2018—An influenza diagnosis for people 65 and older is serious. Up to 85 percent of influenza-related deaths occur in older adults, the Centers for Disease Control (CDC) and Prevention reports.
Mar. 1, 2018—The Tennessee Ambulance Service Association (TASA) has named Vanderbilt LifeFlight’s Tim Bell the Larry Griffin Paramedic of the Year.
Mar. 1, 2018—James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.
Mar. 1, 2018—For the second week, the annual reputation survey for U.S. News & World Report Best Hospitals rankings is available on the Doximity website (www.doximity.com). Physicians who are board certified in one of the 16 adult or 10 pediatric specialties included in the reputation survey have until March 22 to log in to the Doximity website and vote.
Mar. 1, 2018—Less than 20 years after it was developed, a thin, resilient sheet of carbon atoms with remarkable properties known as graphene is transforming biomedical fields as far flung as tissue engineering, neuroprosthetics and drug discovery.